NALDI, MARINA
 Distribuzione geografica
Continente #
NA - Nord America 3335
EU - Europa 3000
AS - Asia 1367
AF - Africa 151
SA - Sud America 15
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
Totale 7880
Nazione #
US - Stati Uniti d'America 3305
GB - Regno Unito 1023
IT - Italia 634
VN - Vietnam 546
CN - Cina 507
SE - Svezia 353
DE - Germania 253
UA - Ucraina 247
IN - India 221
FR - Francia 162
RU - Federazione Russa 135
EE - Estonia 79
ZA - Sudafrica 78
TG - Togo 54
IR - Iran 31
CA - Canada 23
KR - Corea 18
SC - Seychelles 16
CH - Svizzera 15
ES - Italia 14
HR - Croazia 13
PT - Portogallo 13
TR - Turchia 13
BE - Belgio 12
BR - Brasile 9
GR - Grecia 8
MX - Messico 7
NL - Olanda 7
PL - Polonia 7
EU - Europa 6
BG - Bulgaria 5
CL - Cile 5
ID - Indonesia 5
JP - Giappone 5
RO - Romania 5
TW - Taiwan 5
AT - Austria 4
AU - Australia 4
LB - Libano 4
DK - Danimarca 3
SG - Singapore 3
BD - Bangladesh 2
CZ - Repubblica Ceca 2
HK - Hong Kong 2
MA - Marocco 2
PK - Pakistan 2
SM - San Marino 2
EC - Ecuador 1
IE - Irlanda 1
IQ - Iraq 1
MD - Moldavia 1
MK - Macedonia 1
NC - Nuova Caledonia 1
NZ - Nuova Zelanda 1
SI - Slovenia 1
SN - Senegal 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 7880
Città #
Southend 948
Fairfield 468
Dong Ket 374
Wilmington 252
Houston 243
Princeton 230
Woodbridge 225
Bologna 207
Ashburn 206
Cambridge 181
Seattle 179
Ann Arbor 171
Chandler 165
Jacksonville 165
Westminster 99
Berlin 88
Nanjing 81
Padova 76
Medford 58
Jinan 55
Shenyang 55
Lomé 54
Hebei 46
Saint Petersburg 44
Redmond 42
San Diego 42
Falls Church 40
Beijing 38
Redwood City 36
Changsha 32
Des Moines 29
Nanchang 27
Dearborn 25
Milan 24
Tianjin 21
Jiaxing 20
Mahé 16
Guangzhou 15
Hangzhou 15
Ottawa 15
Norwalk 14
Fremont 13
Haikou 12
Brussels 11
Taiyuan 11
Taizhou 11
Verona 11
Zhengzhou 10
Rome 9
San Venanzo 9
Frankfurt Am Main 8
Lisbon 8
Costa Mesa 7
Kunming 7
Lausanne 7
Toronto 7
Lanzhou 6
Nagold 6
Ardabil 5
Chicago 5
Cislago 5
Fuzhou 5
Madrid 5
Napoli 5
Phoenix 5
Trieste 5
Istanbul 4
Leawood 4
Ningbo 4
Palmitinho 4
Piacenza 4
San Jose 4
Scafati 4
Sofia 4
São Paulo 4
Zanjan 4
Amsterdam 3
Boardman 3
Changchun 3
Chengdu 3
Dallas 3
Frattamaggiore 3
Kaohsiung 3
Kiev 3
Las Palmas 3
Las Vegas 3
Leeds 3
London 3
Mozzate 3
Muizenberg 3
San Francisco 3
Sanayi 3
Tokyo 3
Ulan-ude 3
Vienna 3
Wayne 3
Üsküdar 3
Aachen 2
Andover 2
Bremen 2
Totale 5423
Nome #
Advanced analytical methodologies in Alzheimer's disease drug discovery 172
Discovery of novel benzofuran-based compounds with neuroprotective and immunomodulatory properties for Alzheimer's disease treatment 160
Characterisation of the conjugate of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin with lactosaminated human albumin by 13C NMR spectroscopy. 138
STABILITY OF ASCORBIC ACID IN COSMETIC FORMULATION: PROTECTIVE ROLE OF RESVERATROL AND MELATONIN 135
null 135
Albumin homodimers in patients with cirrhosis: clinical and prognostic relevance of a novel identified structural alteration of the molecule. 132
AFM study of F-actin on chemically modified surfaces 119
ON-LINE GLYCAN RELEASE AND ANALYSIS BY AN INTEGRATED PNGASE F-IMER LC-ESI-Q-TOF APPROACH 117
Structural basis for the magnesium-dependent activation of transketolase from Chlamydomonas reinhardtii 115
Synthesis, cytotoxicity and anti-cancer activity of new alkynyl-gold(I) complexes 113
Analysis of human histone H4 by capillary electrophoresis in a pullulan-coated capillary, LC-ESI-MS and MALDI-TOF-MS 110
Exploiting the chalcone scaffold to develop multifunctional agents for Alzheimer’s disease 107
Antioxidant and cytoprotective effects of a wheat-derived non specific lipid transfer protein 2 (nsLTP2) on vascular endothelial cells 103
Antitumoral Efficacy of Two Turmeric Extracts According to Different Extraction Methods in Hepatocellular Carcinoma Cell Lines 102
ANTIPROLIFERATIVE ACTIVITY OF ENANTIOMERICALLY PURE (R) AND (S)-9-HYDROXYSTEARIC ACID IN HT29 COLON CANCER CELLS. 100
AFM study of F-actin on chemically modified surfaces 100
Dual-Acting Cholinesterase-Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo 100
null 99
A fast and validated mass spectrometry method for the evalutation of human serum albumin structural modifications in the clinical field. 98
HS-SPME-GC-MS for the quantitation and chiral characterization of camphor and menthol in creams 97
Mass spectrometry characterization of circulating human serum albumin microheterogeneity in patients with alcoholic hepatitis. 97
Acetylcholinesterase oriented immobilization on nanopatterned bilayered surfaces for biosensing devices 96
Mechanism and stereoselectivity of HDAC I inhibition by (R)-9-hydroxystearic acid in colon cancer. 95
Rapid MALDI-TOF-MS analysis in the study of interaction between whole bacterial cells and human target molecules: binding of Bifidobacterium to human plasminogen 94
IMMOBILIZED ENZYMES AS TOOLS IN DRUG DISCOVERY 92
null 92
Simple and rapid LC-MS method for the determination of circulating albumin microheterogeneity in veal calves exposed to heat stress 92
9-Hydroxystearic acid and sulforaphane: two natural HDAC inhibitors with distinct effects on HT29 cells. 91
Amyloid beta-Peptide 25-35 Self Assembly and Its Inhibition: A Model Undecapeptide System to Gain Atomistic and Secondary Structure Details of the Alzheimer's Disease Process and Treatment 91
9-HSA INDUCES APOPTOSIS AND INCREASES SENSITIVITY TO IMATINIB IN IMATINIB RESISTANT COLON CANCER CELLS 90
Immobilized Enzyme Reactors: an Overview of Applications in Drug Discovery from 2008 to 2018 90
Indole derivative interacts with estrogen receptor beta and inhibits human ovarian cancer cell growth 90
Headspace solid-phase microextraction gas chromatography-mass spectrometry (HS SPME-GC-MS) determination of odorants in green tea 87
A MULTI-METHODOLOGICAL APPROACH FOR BETA-AMYLOID AGGREGATION AND INHIBITION STUDIES 87
Mass spectrometric characterization of human serum albumin dimer: A new potential biomarker in chronic liver diseases. 87
Isolation and Characterization of Wheat Derived Nonspecific Lipid Transfer Protein 2 (nsLTP2) 87
Fluorescence biosensing micropatterned surfaces based on immobilized human acetylcholinesterase 85
AMYLOID-b-PEPTIDE SELF ASSEMBLY KINETICS BY AFM AND MALDI-TOF MASS SPECTROMETRY 84
Unveiling the Biochemistry of the Epigenetic Regulator SMYD3 82
Kinetic characterization of amyloid-beta 1-42 aggregation with a multimethodological approach. 81
UHPLC determination of catechins for the quality control of green tea 81
ALZHEIMER'S DISEASE DRUG DISCOVERY: NEW ANALYTICAL APPROACHES FOR LEAD SELECTION AND OPTIMIZATION PBA 2009 (20h International Symposium on Pharmaceutical and Biomedical Analysis), Agra, India 01-04 Marzo 2009 79
null 79
CE Analysis of Basic Proteins and H4 Human Histones using a Pullulan-Coated Capillary 78
Development and characterization of beta-secretase monolithic micro-immobilized enzyme reactor for on-line high-performance liquid chromatography studies 78
Multiwell fluorometric and colorimetric microassays for the evaluation of beta-secretase (BACE-1) inhibitors. 78
New insights into the altered binding capacity of pharmaceutical-grade human serum albumin: site-specific binding studies by induced circular dichroism spectroscopy 78
Towards automation in protein digestion: Development of a monolithic trypsin immobilized reactor for highly efficient on-line digestion and analysis 77
null 77
ANALYTICAL STRATEGIES FOR THE CHARACTERIZATION OF PROTEIN AGGREGATION AND INHIBITION IN HUMAN DISEASES 76
Discovery of sustainable drugs for Alzheimer's disease: cardanol-derived cholinesterase inhibitors with antioxidant and anti-amyloid properties 76
Structural characterization of p53 isoforms due to the polymorphism at codon 72 by Mass Spectrometry and Circular Dichroism. 75
Analytical approaches in Alzheimer’s disease Drug Discovery 74
Posttranscriptional changes of serum albumin: clinical and prognostic meaning in hospitalized patients with cirrhosis. 74
Immobilized enzyme-based analytical tools in the -omics era: recent advances 73
null 72
Cell cycle arrest induced by sulforaphane in human colon carcinoma cells HT29 is associated with the hyperacetylation of histone H4. 72
BIOLOGICAL EFFECTS OF A NEW CLASS I HDAC SELECTIVE INHIBITOR IN HT29 COLON CANCER CELLS. 72
Ischemia-modified albumin: a marker of bacterial infection in hospitalized patients with cirrhosis. 72
Histone proteins determined in a human colon cancer by high-performance liquid chromatography and mass spectrometry 71
Application of ESI-MS method for detailed characterization of GSK-3β inhibitors by monitoring GSM peptide phosphorylation.Angelini Farmaceutici. 70
A patent review of butyrylcholinesterase inhibitors and reactivators 2010–2017 70
Histone post-translational modifications by HPLC-ESI-MS after HT29 cell treatment with histone deacetylase inhibitors 69
HEADSPACE SOLID-PHASE MICROEXTRACTION GAS CHROMATOGRAPHY-MASS SPECTROMETRY (HS SPME-GC-MS) DETERMINATION OF ODORANTS IN GREEN TEA 68
Hystones’ isoforms determined by HPLC-MS 67
- Application of an ESI-MS method enabling the discovery of new non-ATP competitive GSK-3beta inhibitors. 67
Investigating in vitro amyloid peptide 1−42 aggregation: Impact of higher molecular weight stable adducts 66
HISTONE POST-TRANSLATIONAL MODIFICATIONS DETERMINED BY HIGH-PRESSURE LIQUID CHROMATOGRAPHY AND MASS SPECTROMETRY 65
IDENTIFICATION OF HISTONE MODIFICATIONS INVOLVED IN HDACs INHIBITION BY SUBEROYLANILIDE HYDROXAMIC ACID. 65
The role of Chromatography in Alzheimer’s Disease Drug Discovery. 65
ACETYLCHOLINESTERASE-BASED ANALYTICAL TOOLS FOR DRUG SCREENING 64
Application of an ESI-MS method enabling the discovery of new non-ATP competitive GSK-3beta inhibitors. 64
Development of Beta-secretase monolithic micro-imer (immobilized enzyme reactor) for on-line HPLC studies 63
Peptide mass mapping of acetylated isoforms of histone H4 from HT29 colon cancer cells 63
IDENTIFICATION OF HISTONE MODIFICATIONS INVOLVED IN HDAC1 INHIBITION BY 9-HSA 62
HPLC determination of β-secretase activity on monolithic CIM disks 62
Histones post-translational modifications in colon cancer cell line determined by HPLC-ESI-MS and Maldi-Tof for the characterization of deacetylase inhibitors 62
In vitro thrombogenicity of drug-eluting and bare metal stents 58
UHPLC ANALYSIS OF CATECHINS IN GREEN TEAS 57
Mass Spectrometry as efficient tool for the characterization of amyloid peptide 25-35 self-assembly species in aggregation and inhibition studies 57
Polycyclic Maleimide-based Scaffold as New Privileged Structure for Navigating the Cannabinoid System Opportunities 57
The cell cycle arrest induced by sulforaphane in human colon carcinoma cells HT29 is associated with the hyperacetylation of histone H4. 54
HISTONE POST-TRANSLATIONAL MODIFICATIONS BY HPLC-ESI-MS AFTER HT29 CELL TREATMENT WITH HDACS INHIBITORS. 53
Redox-sensitive structural features of transketolase from Chlamydomonas reinhardtii (CrTK) 53
Development of beta-secretase monolithic micro-IMER: characterization, activity and inhibition studies 52
Self-assembly of biomolecules: AFM study of F-actin on unstructured and nanostructured surfaces 50
PROTEIN GLYCOSILATION ANALYSIS BY AN INTEGRATED PNGASE-F-IMER-LC-ESI-Q-TOF APPROACH 50
GA‐RAGE – Effetti dell’albumina glicata plasmatica sulla stimolazione di RAGE nel diabete mellito di tipo 2 con complicanze renali 50
Development of a new micro-patterned bio-sensing surface to screen for acetylcholinesterase PAS binders 46
β-Amyloid-CORMs interaction monitoring by LC-ESI/MS and Circular Dichroism studies 46
New Coumarin derivatives as cholinergic and cannabinoid system modulators 46
Discovery of an Allosteric Ligand Binding Site in SMYD3 Lysine Methyltransferase 45
Evidence of class I HDACs inhibition and cell cycle block in human carcinoma cells after (R) or (S)-9- HSA treatment 44
EPITOPE IDENTIFICATION OF GLYCATED HSA AND THE EXTRACELLULAR REGION OF HUMAN RAGE BY SPR AND AFFINITY-MS SPECTROMETRY 44
A multi-methodological approach for the investigation of β-Amyloid-CORMs interaction: an LC-ESI/MS and Circular Dichroism study. 43
Tacrine-O-protected phenolics heterodimers as multitarget-directed ligands against Alzheimer's disease: Selective subnanomolar BuChE inhibitors 43
Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications 42
PROTEOMIC ANALYSIS OF POST-TRANSLATIONAL MODIFICATIONS OF HUMAN HISTONES IN CANCER DRUG DISCOVERY 41
Interaction between commercial glycated HSA and the extracellular region of human RAGE: a SPR-based study 41
Integrated analytical methodologies for Alzheimer's disease drug discovery 41
Totale 7879
Categoria #
all - tutte 10630
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10630


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018218 0000 65 16 0018020
2018/2019763 22751181 2287 4254 7512264108
2019/20202385 4067756142 188208 246338 277186117144
2020/20211774 3171194272 4768 71125 1558999570
2021/20222278 2578593124 213128 67198 114177422400
2022/2023720 22531515723 00 00 0000
Totale 8201